Group One Trading, L.P. Aclaris Therapeutics, Inc. Transaction History

Group One Trading, L.P.

  • $3.01 Billion
  • Q2 2024

A detailed history of Group One Trading, L.P. transactions in Aclaris Therapeutics, Inc. stock. As of the latest transaction made, Group One Trading, L.P. holds 5,549 shares of ACRS stock, worth $11,597. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,549
Previous 133,831 95.85%
Holding current value
$11,597
Previous $165,000 96.36%
% of portfolio
0.0%
Previous 0.01%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$1.01 - $1.36 $129,564 - $174,463
-128,282 Reduced 95.85%
5,549 $6,000
Q1 2024

May 10, 2024
BUY
$0.92 - $1.44 $52,099 - $81,547
56,630 Added 73.35%
133,831 $165,000
Q4 2023

Feb 14, 2024
BUY
$0.64 - $6.49 $5,703 - $57,832
8,911 Added 13.05%
77,201 $81,000
Q3 2023

Nov 09, 2023
BUY
$6.56 - $10.95 $119,779 - $199,936
18,259 Added 36.5%
68,290 $467,000
Q2 2023

Aug 09, 2023
SELL
$7.89 - $10.64 $326,606 - $440,442
-41,395 Reduced 45.28%
50,031 $518,000
Q1 2023

May 12, 2023
BUY
$7.07 - $17.95 $646,381 - $1.64 Million
91,426 New
91,426 $739,000
Q3 2022

Nov 09, 2022
SELL
$13.07 - $18.22 $26,126 - $36,421
-1,999 Reduced 81.39%
457 $7,000
Q2 2022

Aug 11, 2022
SELL
$10.16 - $17.08 $2,600 - $4,372
-256 Reduced 9.44%
2,456 $34,000
Q1 2022

May 12, 2022
SELL
$9.74 - $17.92 $6,886 - $12,669
-707 Reduced 20.68%
2,712 $47,000
Q4 2021

Feb 11, 2022
SELL
$12.27 - $18.49 $32,184 - $48,499
-2,623 Reduced 43.41%
3,419 $50,000
Q3 2021

Nov 12, 2021
BUY
$13.38 - $18.8 $57,172 - $80,332
4,273 Added 241.55%
6,042 $109,000
Q2 2021

Aug 10, 2021
SELL
$17.08 - $29.6 $245,610 - $425,648
-14,380 Reduced 89.05%
1,769 $31,000
Q1 2021

May 12, 2021
SELL
$5.86 - $27.73 $184,496 - $873,051
-31,484 Reduced 66.1%
16,149 $407,000
Q4 2020

Feb 10, 2021
BUY
$2.65 - $7.61 $106,087 - $304,651
40,033 Added 526.75%
47,633 $308,000
Q3 2020

Nov 12, 2020
BUY
$1.5 - $2.71 $7,650 - $13,821
5,100 Added 204.0%
7,600 $20,000
Q2 2020

Aug 13, 2020
BUY
$1.04 - $1.73 $2,600 - $4,325
2,500 New
2,500 $4,000
Q1 2020

May 13, 2020
SELL
$0.75 - $2.18 $8,588 - $24,963
-11,451 Closed
0 $0
Q4 2019

Feb 10, 2020
BUY
$1.02 - $1.97 $9,133 - $17,639
8,954 Added 358.59%
11,451 $22,000
Q3 2019

Nov 12, 2019
SELL
$0.79 - $2.47 $12,707 - $39,729
-16,085 Reduced 86.56%
2,497 $3,000
Q2 2019

Aug 09, 2019
BUY
$2.13 - $7.06 $37,769 - $125,187
17,732 Added 2086.12%
18,582 $41,000
Q1 2019

May 13, 2019
BUY
$5.63 - $7.84 $4,785 - $6,664
850 New
850 $5,000

Others Institutions Holding ACRS

# of Institutions
97
Shares Held
52.4M
Call Options Held
32.4K
Put Options Held
3.3K
View Full List

About Aclaris Therapeutics, Inc.

ACRS Quotes by TradingView
  • Ticker ACRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 66,671,800
  • Market Cap $139M
  • Description
  • Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...
More about ACRS
Track This Portfolio

Track Group One Trading, L.P. Portfolio

Follow Group One Trading, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email